The Effect of Blue-light Filtering Spectacle Lenses on Myopia Progression in Schoolchildren
Does Blue-light Filtering Spectacle Lens Promote Myopia Progression in Schoolchildren
1 other identifier
interventional
148
1 country
1
Brief Summary
The purpose of this study is to investigate if the blue-light filtering spectacle lenses promote myopia progression in schoolchildren.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 15, 2018
CompletedFirst Posted
Study publicly available on registry
May 25, 2018
CompletedStudy Start
First participant enrolled
September 10, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2021
CompletedJanuary 13, 2022
January 1, 2021
3.2 years
May 15, 2018
January 12, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cycloplegic refraction
Refraction done under cycloplegia
2 years
Secondary Outcomes (1)
Axial length
2 years
Study Arms (2)
Conventional anti-reflection coated spectacle lens
NO INTERVENTIONSingle vision lenses with correction of distant refraction and conventional anti-reflection coating
Blue-light filtering spectacle lenses
EXPERIMENTALSingle vision lenses with correction of distant refraction and blue-light filtering coating
Interventions
This is a single vision spectacle lens for correction of distant refractions and filtering out the blue light by providing anti-blue light coating.
Eligibility Criteria
You may qualify if:
- Refraction: myopia of -1.00 dioptres (D) to -5.00D
- Astigmatism: equal or less than -1.50D
- Anisometropia: equal or less than 1.00D
- Best corrected monocular visual acuity: 0.0 LogMAR or better after full correction
- Parents' understanding and acceptance of random allocation of grouping
You may not qualify if:
- any ocular and systemic abnormalities might affect visual functions or refractive development
- prior treatment of myopic control, e.g. drugs, orthokeratology, progressive addition lenses, bifocal lenses, drugs (e.g. atropine), etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre of Myopia Research, School of Optometry, The Hong Kong Polytechnic University
Hong Kong, 00000, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ka Man Chun, PhD
Centre for Myopia Research, The Hong Kong Polytechnic University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 15, 2018
First Posted
May 25, 2018
Study Start
September 10, 2018
Primary Completion
November 30, 2021
Study Completion
November 30, 2021
Last Updated
January 13, 2022
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will not share